Drug class
Long-acting granulocyte colony-stimulating factor (G-CSF) analog; pegylated leukocyte growth factor
Mechanism of action
Binds G-CSF receptors on haematopoietic progenitor cells and neutrophils, stimulating proliferation, differentiation and survival of neutrophil precursors and increasing circulating neutrophil counts.
General use cases
- To decrease the incidence of infection, manifested as febrile neutropenia, in adults with non-myeloid malignancies receiving myelosuppressive anticancer drugs associated with a clinically significant incidence of febrile neutropenia; not indicated for peripheral-blood stem-cell mobilisation
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
